Determinants of Cardiovascular Disease, Kidney Disease and Diabetes

Clinical Trial ID NCT04646408

PubWeight™ 0.00^‹?›

🔗 Visit the ClinicalTrials.gov page for NCT04646408

Top papers

Rank	Title	Journal	Year	PubWeight™‹?›
1	Association of trypanolytic ApoL1 variants with kidney disease in African Americans.	Science	2010	16.00
2	Qualitative research: standards, challenges, and guidelines.	Lancet	2001	15.85
3	The social determinants of health: coming of age.	Annu Rev Public Health	2011	4.98
4	APOL1 genetic variants in focal segmental glomerulosclerosis and HIV-associated nephropathy.	J Am Soc Nephrol	2011	4.80
5	Apolipoprotein L1 gene variants associate with hypertension-attributed nephropathy and the rate of kidney function decline in African Americans.	Kidney Int	2012	3.46
6	The social determinants of health: it's time to consider the causes of the causes.	Public Health Rep	2014	2.15
7	Association of sickle cell trait with chronic kidney disease and albuminuria in African Americans.	JAMA	2014	1.79
8	US Renal Data System 2015 Annual Data Report: Epidemiology of Kidney Disease in the United States.	Am J Kidney Dis	2016	1.37
9	Loss of GSTM1, a NRF2 target, is associated with accelerated progression of hypertensive kidney disease in the African American Study of Kidney Disease (AASK).	Am J Physiol Renal Physiol	2012	0.92
10	Syndemics and the biosocial conception of health.	Lancet	2017	0.82
11	Sickle Cell Trait and the Risk of ESRD in Blacks.	J Am Soc Nephrol	2017	0.75
12	Co-occurring epidemics, syndemics, and population health.	Lancet	2017	0.75
13	The Loss of GSTM1 Associates with Kidney Failure and Heart Failure.	J Am Soc Nephrol	2017	0.75
14	Syndemics: health in context.	Lancet	2017	0.75
15	Non-communicable disease syndemics: poverty, depression, and diabetes among low-income populations.	Lancet	2017	0.75